Sort
17,054 grants matching “genome editing”
Gene Therapy for Inherited Blood Disorders
$1,183,964Andre Larochelle · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL
VISION: ValIdated Systematic IntegratiON of epigenomic data
$1,183,458Ross C Hardison · Pennsylvania State University, The · R24 · FY2020 · DK
Uncovering molecular effectors of mammalian aging
$1,183,000Amy Jo Wagers · Harvard University · DP1 · FY2018 · AG
Novel therapeutic gene editing to induce fetal hemoglobin for sickle cell disease
$1,183,000Mitchell J Weiss · St. Jude Children'S Research Hospital · U01 · FY2023 · HL
Uncovering molecular effectors of mammalian aging
$1,183,000Amy Jo Wagers · Harvard University · DP1 · FY2020 · AG
DNA-mediated recording of cellular history
$1,183,000Alexander F Schier · Harvard University · DP1 · FY2018 · HD
Uncovering molecular effectors of mammalian aging
$1,183,000Amy Jo Wagers · Harvard University · DP1 · FY2021 · AG
Uncovering molecular effectors of mammalian aging
$1,183,000Amy Jo Wagers · Harvard University · DP1 · FY2019 · AG
DNA-mediated recording of cellular history
$1,183,000Alexander F Schier · Harvard University · DP1 · FY2017 · HD
DNA-mediated recording of cellular history
$1,183,000Alexander F Schier · Harvard University · DP1 · FY2019 · HD
Novel therapeutic gene editing to induce fetal hemoglobin for sickle cell disease
$1,183,000Mitchell J Weiss · St. Jude Children'S Research Hospital · U01 · FY2025 · HL
Uncovering molecular effectors of mammalian aging
$1,183,000Amy Jo Wagers · Harvard University · DP1 · FY2022 · AG
A Microphysiological System for Kidney Disease Modeling and Drug Efficacy Testing
$1,180,480Jonathan Himmelfarb · University Of Washington · UG3 · FY2018 · TR
Establishing the POROS Intracellular Delivery System as a Platform for Cellular Therapeutics
$1,180,225Michael M Binkley · Opencell Technologies, Inc. · R44 · FY2022 · CA
Resource Informatics and Production Core
$1,179,669Anne Eagle · University Of Oregon · U41 · FY2018 · HG
Kidney Therapeutics: Translating Discoveries into Prevention, Treatment and Cures for Kidney Diseases
$1,179,001Susan E Quaggin · Northwestern University At Chicago · P30 · FY2018 · DK
Multiplexed high-content assay for toxicity profiling using live iPSC-derived cardiomyocyte lines with lineage-specific barcoding
$1,178,386Mary Ludlam · Cairn Biosciences, Inc. · R44 · FY2018 · TR
Pathogenesis Informs Therapy for Glycosphingolipid and Glycoprotein Disorders
$1,178,336Cynthia Tifft · National Human Genome Research Institute · ZIA · FY2024 · HG
Resource Section
$1,177,031Cathleen M Lutz · Jackson Laboratory · U42 · FY2023 · OD
The NINDS Human Cell and Data Repository
$1,175,650Jay Arnold Tischfield · Rutgers, The State Univ Of N.J. · U24 · FY2016 · NS
A Microphysiological System for Kidney Disease Modeling and Drug Efficacy Testing
$1,174,809Jonathan Himmelfarb · University Of Washington · UH3 · FY2021 · TR
Addressing safety issues by quantify large deletions and chromosomal rearrangements in HBB gene editing
$1,173,874Gang Bao · Rice University · OT2 · FY2020 · HL
The 3D genome in transcriptional regulation across the postnatal life span, with implications for schizophrenia and bipolar disorder
$1,173,570Panagiotis Roussos · Icahn School Of Medicine At Mount Sinai · U01 · FY2020 · MH
Development and Support of the Pathway Tools Software
$1,172,505Peter D Karp · Sri International · R01 · FY2021 · AI
Circuit-Specific Delivery of Large Cargo Across the Nervous Systems of Adult Mammals and Embryos via Novel Engineered Systemic Vectors
$1,172,500Viviana Gradinaru · California Institute Of Technology · DP1 · FY2021 · NS